Clinical Trials Directory

Trials / Completed

CompletedNCT02154126

PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Senseonics, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements (YSI glucose analyzer). The investigation will also evaluate safety of the Senseonics CGM System usage, while in the clinic and during home use.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Glucose Monitoring Device (Senseonics)

Timeline

Start date
2014-05-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2014-06-03
Last updated
2016-01-21

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02154126. Inclusion in this directory is not an endorsement.

PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor (NCT02154126) · Clinical Trials Directory